Eledon Pharmaceuticals (ELDN) Profit After Tax (2013 - 2026)
Eledon Pharmaceuticals (ELDN) reported Profit After Tax of -$39.0 million for Q1 2026, down 500.85% on a YoY basis from $9.7 million in Q1 2025, and down 274.63% quarter-over-quarter from -$10.4 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) Profit After Tax (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals has reported Profit After Tax for 14 years, with the latest figure at -$39.0 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 500.85% year-over-year to -$39.0 million; the trailing twelve-month figure through Mar 2026 stood at -$78.1 million (down 310.11% YoY), and the FY2025 full-year result was -$45.6 million, down 26.07% from the prior year.
- Profit After Tax for Q1 2026 stood at -$39.0 million, down from -$10.4 million in the prior quarter.
- The five-year high for Profit After Tax was $77.0 million in Q3 2024, with the low at -$65.8 million in Q2 2023.
- Historically, Profit After Tax has averaged -$19.1 million across 5 years, with a median of -$11.2 million in 2025.
- Annual changes were most pronounced in 2023 — Profit After Tax slumped 611.15% — and 2024, when it soared 877.01%.
- Eledon Pharmaceuticals' Profit After Tax stood at -$58.4 million in 2022, then surged by 48.45% to -$30.1 million in 2023, then slumped by 48.23% to -$44.6 million in 2024, then soared by 76.65% to -$10.4 million in 2025, then sank by 274.63% to -$39.0 million in 2026.
- The last three Profit After Tax figures came in at -$39.0 million (Q1 2026), -$10.4 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Eledon Pharmaceuticals | 403.04 Mn | 187.00 Mn | - | -39.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.03 Mn |
| Dec 31, 2025 | -10.42 Mn |
| Sep 30, 2025 | -17.46 Mn |
| Jun 30, 2025 | -11.22 Mn |
| Mar 31, 2025 | -6.50 Mn |
| Dec 31, 2024 | -44.62 Mn |
| Sep 30, 2024 | 76.97 Mn |
| Jun 30, 2024 | -44.91 Mn |
| Mar 31, 2024 | -23.63 Mn |
| Dec 31, 2023 | -30.10 Mn |
| Sep 30, 2023 | -9.91 Mn |
| Jun 30, 2023 | -65.76 Mn |
| Mar 31, 2023 | -10.77 Mn |
| Dec 31, 2022 | -58.38 Mn |
| Sep 30, 2022 | -10.47 Mn |
| Jun 30, 2022 | -9.25 Mn |
| Mar 31, 2022 | -9.86 Mn |
| Dec 31, 2021 | -8.81 Mn |
| Sep 30, 2021 | -9.82 Mn |
| Jun 30, 2021 | -7.38 Mn |